Ontology highlight
ABSTRACT: Introduction
Both Δ9 Tetrahydrocannabidiol (THC) and cannabidiol (CBD) components of cannabis, have been shown to have anticonvulsant effects. Cannabis oils are used to treat seizures in drug-resistant epilepsy (DRE). Recent trials provide data on dosing, side effects, and efficacy of CBD, yet there is a paucity of information on THC in epilepsy. Primary objective was to establish dosing and tolerability of TIL-TC150 - a cannabis plant extract produced by Tilray®, containing 100 mg/mL CBD and 2 mg/mL THC- in children with Dravet syndrome. Secondary objectives were to assess impact of therapy on seizures, electroencephalogram (EEG) and quality of life.Methods
Twenty children received add-on therapy with TIL-TC150. The dose ranged from 2 to 16 mg/kg/day
SUBMITTER: McCoy B
PROVIDER: S-EPMC6144444 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature